Amgen Inc

AMGN remains in Stage 2 advancing with Higher Highs & Higher Lows and rising EMAs confirming medium-term bullish structure. Price is holding above the 9-/20-/50-EMA cluster following a shallow pullback, with RSI near but below overbought extremes. Short-term conditions favor participation now on shallow pullbacks into the EMAs or on continuation above recent highs.

• ↑Revenue rose 9% YoY to $8.1B, driven by 14% volume growth
• ↑Non-GAAP operating margin of 45% highlights strong profitability
• ↓Negative growth trends and severe revision risks signal outlook deterioration